88 related articles for article (PubMed ID: 18433795)
21. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
22. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
Sánchez Y; Calle C; de Blas E; Aller P
Chem Biol Interact; 2009 Nov; 182(1):37-44. PubMed ID: 19720055
[TBL] [Abstract][Full Text] [Related]
23. [Mechanisms of the antiaggregation activity of 1,4-naphthoquinone derivatives].
Levin GS; Kalmykova IB; Shneĭvaĭs VB; Kamenetskaia TsL; Dregeris IaIa
Farmakol Toksikol; 1989; 52(5):37-41. PubMed ID: 2599075
[TBL] [Abstract][Full Text] [Related]
24. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.
Heptinstall S; Espinosa DI; Manolopoulos P; Glenn JR; White AE; Johnson A; Dovlatova N; Fox SC; May JA; Hermann D; Magnusson O; Stefansson K; Hartman D; Gurney M
Platelets; 2008 Dec; 19(8):605-13. PubMed ID: 19012178
[TBL] [Abstract][Full Text] [Related]
25. Amyloid beta peptide-activated signal pathways in human platelets.
Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY
Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury.
Akhlaghi M; Bandy B
J Mol Cell Cardiol; 2009 Mar; 46(3):309-17. PubMed ID: 19133271
[TBL] [Abstract][Full Text] [Related]
27. Splitomicin suppresses human platelet aggregation via inhibition of cyclic AMP phosphodiesterase and intracellular Ca++ release.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Thromb Res; 2009 Jun; 124(2):199-207. PubMed ID: 19327818
[TBL] [Abstract][Full Text] [Related]
28. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity.
Fontenele JB; Leal LK; Silveira ER; Felix FH; Bezerra Felipe CF; Viana GS
J Pharm Pharmacol; 2009 Apr; 61(4):511-5. PubMed ID: 19298699
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of oligopeptides from hen egg white on both human platelet aggregation and blood coagulation.
Cho HJ; Kittaka R; Abdou AM; Kim M; Kim HS; Lee DH; Park HJ
Arch Pharm Res; 2009 Jun; 32(6):945-53. PubMed ID: 19557374
[TBL] [Abstract][Full Text] [Related]
30. Direct treatment of mouse or human blood with soluble 5'-nucleotidase inhibits platelet aggregation.
Hart ML; Köhler D; Eckle T; Kloor D; Stahl GL; Eltzschig HK
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1477-83. PubMed ID: 18511695
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats.
Li D; Peng J; Xin HY; Luo D; Zhang YS; Zhou Z; Jiang DJ; Deng HW; Li YJ
Peptides; 2008 Oct; 29(10):1781-8. PubMed ID: 18625276
[TBL] [Abstract][Full Text] [Related]
32. Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicin-induced toxicity in cardiomyocytes.
Du Y; Lou H
Eur J Pharmacol; 2008 Sep; 591(1-3):96-101. PubMed ID: 18611398
[TBL] [Abstract][Full Text] [Related]
33. Signaling pathways for induction of platelet aggregation by SAS tongue cancer cells--a mechanism of hematogenous metastasis.
Chang MC; Chan CP; Ho YS; Lee JJ; Lin PS; Lin BR; Huang YL; Hahn LJ; Yeh HW; Wang YJ; Jeng JH
J Oral Pathol Med; 2009 May; 38(5):434-40. PubMed ID: 18811671
[TBL] [Abstract][Full Text] [Related]
34. 2'-Ethoxy-5'-methoxy-2-(5-methylthienyl)chalcone inhibits collagen-induced protein tyrosine phosphorylation and thromboxane formation during platelet aggregation and adhesion.
Lo HM; Huang TF; Lin CN; Peng HC; Wu WB
Pharmacology; 2009; 84(3):145-52. PubMed ID: 19690443
[TBL] [Abstract][Full Text] [Related]
35. [The effect of compounds with antioxidant properties on thrombocyte functional activity].
Spasov AA; Ostrovskiĭ OV; Ivakhnenko IV; Kosolapov VA; Anisimova VA
Eksp Klin Farmakol; 1999; 62(1):38-40. PubMed ID: 10198764
[TBL] [Abstract][Full Text] [Related]
36. Synthetic polymeric substrates as potent pro-oxidant versus anti-oxidant regulators of cytoskeletal remodeling and cell apoptosis.
Sung HJ; Chandra P; Treiser MD; Liu E; Iovine CP; Moghe PV; Kohn J
J Cell Physiol; 2009 Mar; 218(3):549-57. PubMed ID: 19016472
[TBL] [Abstract][Full Text] [Related]
37. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of platelet aggregation by 1-methyl-4-phenyl pyridinium ion (MPP+) through ATP depletion: Evidence for the reduced platelet activities in Parkinson's disease.
Lim KM; Kim HH; Bae ON; Noh JY; Kim KY; Kim SH; Chung SM; Shin S; Kim HY; Chung JH
Platelets; 2009 May; 20(3):163-70. PubMed ID: 19437333
[TBL] [Abstract][Full Text] [Related]
39. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
Jagroop IA; Mikhailidis DP
Clin Appl Thromb Hemost; 2008 Jul; 14(3):295-302. PubMed ID: 18445610
[TBL] [Abstract][Full Text] [Related]
40. Augmentation of U46619 induced human platelet aggregation by aspirin.
Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
